ALNYLAM SUBMITS REGULATORY APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR VUTRISIRAN FOR THE TREATMENT OF ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY

Reuters · 10/16 12:00

Please log in to view news